- 1) Kanzaki, H., Imura, D., Nitoda, T., and Kawazu, K., Effective production of a dehydro cyclic dipeptide albonoursin with pronuclear fusion inhibitory activity. II. Biosynthetic and bioconversion studies. J. Antibiotics, 53, 58–62 (2000).
- 2) Kanzaki, H., Imura, D., Nitoda, T., and Kawazu, K., Enzymatic conversion of cyclic dipeptides to dehydro derivatives that inhibit cell division. J. Biosci. Bioeng., 90, 86–89 (2000).
- 3) Kanzaki, H., Yanagisawa, S., and Nitoda, T., Biosynthetic intermediates of tetradehydro cyclic dipeptide albonoursin produced by Streptomyces albulus KO-23. J. Antibiotics, 53, 1257–1264 (2000).
- 4) Kanzaki, H., Yanagisawa, S., Kanoh, K., and Nitoda, T., A novel potent cell cycle inhibitor dehydrophenylahistin: enzymatic synthesis and inhibitory activity toward sea urchin embryo. J. Antibiotics, 55, 1042–1047 (2002).
- 5) Kanzaki, H., Yanagisawa, S., and Nitoda, T., Enzymatic synthesis of dehydro cyclo(His-Phe)s, analogs of the potent cell cycle inhibitor, dehydrophenylahistin, and their inhibitory activities toward cell division. Biosci. Biotechnol. Biochem., 68, 2341–2345 (2004).
- 6) Kanoh, K., Kohno, S., Katada, J., Takahashi, J., Uno, I., and Hayashi, Y., Synthesis and biological activities of phenylahistin derivatives. Bioorg. Med. Chem., 7, 1451–1457 (1999).
- 7) Arunrattiyakorn, P., Nitoda, T., and Kanzaki, H., Enzymatic conversion-based method for screening cyclic dipeptide-producing microbes. Peptides, 27, 633–639 (2006).
- 8) Kanzaki, H., Imura, D., Sashida, R., Kobayashi, A., and Kawazu, K., Effective production of a dehydro cyclic dipeptide albonoursin with pronuclear fusion inhibitory activity. I. Taxonomy and fermentation. J. Antibiotics, 52, 1017–1022 (1999).
Full access
Enzymatic Synthesis of Dehydroderivatives from Proline-Containing Cyclic Dipeptides and Their Effects toward Cell Division
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.